Hamlet BioPharma Participates in Swiss Nordic Bio 2024
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, is proud to announce its participation in the Swiss Nordic Bio 2024 conference, set to take place in Zurich on March 7, 2024. This high-level partnering and investor conference is dedicated to connecting healthcare innovations, investors, and industry leaders from Switzerland and the Nordic countries. The Swiss Nordic Bio conference gathers Europe's leading executives from the biotech and pharmaceutical sectors, alongside prominent investors. With over 200 participants,